These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7303496)

  • 1. [Calcitonin therapy - possibilities and problems].
    Pacovský V
    Vnitr Lek; 1981 Jul; 27(7):625-31. PubMed ID: 7303496
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic possibilities in paraneoplastic hypercalcemia].
    Schürer CC; Peters U; Fischer JT
    Med Welt; 1981 Aug; 32(32-33):1219-21. PubMed ID: 6456397
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcitonin therapy of the hypercalcemia syndrome].
    Várvölgyi C; Mátyus J; Lörincz I
    Orv Hetil; 1988 Jun; 129(25):1343-4. PubMed ID: 3194130
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcitonin therapy for bone disease and hypercalcemia.
    Avioli LV
    Arch Intern Med; 1982 Nov; 142(12):2076-9. PubMed ID: 7138154
    [No Abstract]   [Full Text] [Related]  

  • 5. Salmon calcitonin in the treatment of hypercalcemia.
    Silva OL; Becker KL
    Arch Intern Med; 1973 Sep; 132(3):337-9. PubMed ID: 4798763
    [No Abstract]   [Full Text] [Related]  

  • 6. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.
    Camisasca M; Crosignani A; Battezzati PM; Albisetti W; Grandinetti G; Pietrogrande L; Biffi A; Zuin M; Podda M
    Hepatology; 1994 Sep; 20(3):633-7. PubMed ID: 8076921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rehydration as a diagnostic and therapeutic measure in hypercalcemia including an assessment of the calcium-lowering effect of porcine calcitonin.
    Andersen M
    Acta Med Scand; 1972 Oct; 192(4):347-51. PubMed ID: 5081074
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thyrocalcitonin, betamethasone and hydration in hypercalcemia caused by bone metastases of breast carcinoma].
    Azzoini P
    Clin Ter; 1981 Apr; 97(2):147-52. PubMed ID: 7237955
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Hypercalcemia in malignant bone diseases and its management. Studies on calcium metabolism and the use of calcitonin.
    Takatsuki K; Yodoi J; Wakisaka G; Yamamoto I; Hamamoto K
    Calcif Tissue Res; 1974; 15(2):157. PubMed ID: 4844394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypercalcemia].
    Thorsen N; Ditzel J
    Ugeskr Laeger; 1968 Oct; 130(42):1761-6. PubMed ID: 4972886
    [No Abstract]   [Full Text] [Related]  

  • 11. Alendronate in the treatment of osteoporosis.
    Adami S
    Aging (Milano); 1998 Apr; 10(2):159-60. PubMed ID: 9666215
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypercalcemia and hyperuricemia in a patient with IgG myeloma treated with thyrocalcitonin].
    Garijo Forcada JM; Aguado Pérez M
    Rev Clin Esp; 1973 May; 129(3):289-92. PubMed ID: 4714689
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of synthetic eel calcitonin on hypercalcemia--with special reference to its acute effect].
    Sakai T; Suzuki J; Marushige F
    Horumon To Rinsho; 1979 Jan; 27(1):71-6. PubMed ID: 284873
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Hypercalcemia in patients with malignant diseases and treatment with porcine calcitonin.
    Abe K; Adachi I
    Calcif Tissue Res; 1974; 15(2):153-4. PubMed ID: 4844388
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of calcitonin treatment in hypercalcemia associated with malignant neoplasms].
    Miura S; Yoshida Y; Murai H
    Horumon To Rinsho; 1975 Aug; 23(8):809-15. PubMed ID: 1238199
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute therapy of hypercalcemic hyperparathyroidism using calcitonin].
    Hesch RD; Hüfner M; Paschen K; zur Mühlen A von
    Dtsch Med Wochenschr; 1971 Apr; 96(17):764-5. PubMed ID: 5552861
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thyrocalcitonin: therapeutic confirmation in neoplastic hypercalcemia].
    Azzoni P; Turco P; Dal Negro R; Govoni P
    Clin Ter; 1977 Sep; 82(5):483-8. PubMed ID: 923189
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcitonin: its therapeutic use].
    Heynen G
    Brux Med; 1978 Mar; 58(3):137-9. PubMed ID: 630449
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effect of synthetic eel calcitonin on patients with hypercalcemia (author's transl)].
    Tomita A; Nakagawa H; Takita S; Uchikawa K; Wanibe H
    Horumon To Rinsho; 1979 Aug; 27(8):897-902. PubMed ID: 487625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.